A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4422 (2006.01) A61K 9/44 (2006.01) A61K 31/4178 (2006.01) A61K 31/4184 (2006.01)
Patent
CA 2614085
The invention relates to a pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of at least one angiotensin II antagonist, characterized in that the active principle combination is released in the body in a controlled (modified) manner, and to methods for the production thereof, their use as medicaments, their use for the prophylaxis, secondary prophylaxis and/or treatment of diseases as well as to their use for producing a medicament for the prophylaxis, secondary prophylaxis and/or treatment of diseases.
La présente invention concerne une forme dosifiée pharmaceutique contenant une association de principes actifs de Nifédipine ou Nisoldipine et au moins un antagoniste de l'angiotensine-II. L'invention est caractérisée en ce que l'association de principes actifs est libérée de manière contrôlée (modifiée) dans l'organisme. L'invention concerne également son procédé de production, son utilisation en tant que médicament, son utilisation pour la prophylaxie, la prophylaxie secondaire et/ou le traitement de maladies ainsi que son utilisation pour produire un médicament destiné à la prophylaxie, la prophylaxe secondaire et/ou le traitement de maladies.
Benke Klaus
Huetter Joachim
Ohm Andreas
Tinel Hanna
Bayer Healthcare Ag
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Pharmaceutical dosage form containing an active principle... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical dosage form containing an active principle..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical dosage form containing an active principle... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1484655